期刊文献+

TOX3基因rs3803662位点基因型与乳腺癌病理、临床特征的关系 被引量:3

Relationship between genotype of rs3803662 locus in TOX3 gene and clinical and pathological characteristics of breast cancer
暂未订购
导出
摘要 目的 探讨TOX3基因rs3803662位点基因型与病理、临床特征的关系.方法 采用TaqMan 单核苷酸多态性(SNP)法检测TOX3基因rs3803662位点基因型,分析不同病理特征和临床特征与基因型分布的关系.结果 病理类型、组织分级、淋巴结转移、ER状态等病理特征与rs3803662位点基因型分布无关(P>0.05);IDC型和SBR3级变异型基因携带率分别显著高于DCIS型和SBR2级(P<0.05).诊断时年龄、临床分期、月经持续时间(年)及月经状态等临床特征与rs3803662基因型分布有关(P<0.05),纯合突变携带率随月经持续年限增加而显著增加(PTrend=0.034).结论 TOX3基因rs3803662位点变异型基因与病理类型和组织分级有关,与临床分期、月经持续时间等临床特征有关. Objective To investigate the relationship between genotype of rs3803662 locus in TOX3 gene and clinical and pathological characteristics. Methods The TaqMan Single nueleotide polymorphism(SNP) assay was carried out to detect the dimorphism at the rs3803662 SNP loci. The distribution of genotype was com- pared in the different clinical characteristics and pathological characteristics. Results The distribution of rs3803662 genotype did not associate with pathological characteristics(P 〉 0.05 ) ,such as pathological type, his- tological grade, Lymph node involvement, ER status and etc. The proportion of variant genotype carriers was signif- icantly higher in the IDC type and SBR3 grade than DCIS type and SBR2 grade, respectively ( P 〈 0. 05 ). The distribution of rs3803662 genotype was associated with age at diagnosis, clinical stages, menstrual duration and clinical characteristics( P 〈 0.05 ). The rate of homozygous mutation carrier increased significantly with the menstrual duration ( PTrend = 0. 034). Conclusion The variant genotype of rs3803662 in TOX3 was associated with DIC and SBR3. The distribution of rs3803662 genotype was associated with clinical stages, menstrual duration and clinical characteristics.
出处 《实用肿瘤学杂志》 CAS 2011年第6期501-505,共5页 Practical Oncology Journal
基金 黑龙江省教育厅科学技术研究项目(11541128)
关键词 乳腺癌 TOX3 单核苷酸多态性 临床特征 病理特征 Breast cancer TOX3 SNP Clinical characteristics Pathological characteristics
  • 相关文献

参考文献14

  • 1Tian FG, Guo XY, Zhang HY. Advancement in diagnosis and treatment of breast cancer[J]. Cancer Res Clin,2005, 17:58 -60.
  • 2Easton DF, Pooley KA, Dunning AM, et al. Genome - wide association study identifies novel breast cancer susceptibilityloci[ J]. Nature,2007,447 (7148) : 1087 - 1093.
  • 3Reeves GK, Travis RC, Green J, et al. Incidence of breast cancer and its subtypes in relation to individual and multi- ple low - penetrance genetic susceptibility Loci [ J ]. JAMA, 2010,304(4) :426 -434.
  • 4Travis RC, Reeves GK, Green J, et al. Gene - environment interactions in 7610 women with breast cancer: prospective evidence from the Million Women Study[ J]. Lancet,2010, 375(9732) :2143 -2151.
  • 5Garcia - Closas M, Hall P, Nevanlinna H, et al. Heterogenei- ty of breast cancer associations with five susceptibility loci by clinical and pathological characteristics[ OL]. PLoS Gen- et,2008,4(4) : e1000054.
  • 6Stacey SN, Manolescu A, Sulem P, et al. Common variants on chromosomes 2q35 and 16q12 confer susceptibility to es- trogen receptor - positive breast cancer [ J ]. Nat Genet, 2007,39 (7) : 865 - 869.
  • 7Li L, Zhou X, Huang Z, et al. TNRC9/LOC643714 polymor- phisms are not associated with breast cancer risk in Chinese women[ J ]. Eur J Cancer Prey,2009,18 (4) :285 - 290.
  • 8Ruiz- Narvaez EA, Rosenberg L, Cozier YC, et al. Polymor- phisms in the TOX3/LOC643714 locus and risk of breast cancer in African -American women[ J]. Cancer Epidemiol Biomarkers Prev,2010,19 (5) : 1320 - 1327.
  • 9Liang J, Chen P, Hu Z, et al. Genetic variants in trinucleoti- de repeat - containing 9 (TNRC9) are associated with risk of estrogen receptor positive breast cancer in a Chinese popula- tion[ J]. Breast Cancer Res Treat, 2010, 124 ( 1 ) :237 - "~.4.1.
  • 10Huijts PE, Vreeswijk MP, Kroeze - Jansema KH, et al. Clinical correlates of low - risk variants in FGFR2, TNRC9,MAP3K1,LSP1 and 8q24 in a Dutch cohort of incident breast cancer cases [ OL ]. Breast Cancer Res, 2007,9(6) :R78.

共引文献7

同被引文献39

  • 1田富国,郭向阳,张华一.乳腺癌诊治研究新进展[J].肿瘤研究与临床,2005,17(S1):58-60. 被引量:14
  • 2姚文庆,董国贤,辛裕明,杨萍,王健民,李丙仁,付立人.沈阳市区女性乳腺癌危险因素研究[J].实用肿瘤学杂志,1989,3(3):19-21. 被引量:8
  • 3Perou CM, Sorlie T, Eisen MB, et al. Molecular portrait of human breast tumors [ J ]. Nature, 2000,406 ( 6797 ) : 747 - 752.
  • 4Sorlie T, Tibshirani R, Parker J, et al. Repeated observation of breast tumor subtypes in independent gene expression da- ta sets[ J]. PNAS,2003,100(14) :8418 - 8423.
  • 5A1 - Hajj M, Wicha MS, Benito - Hernandez A, et al. Pro- spective identification of tumorigenic breast cancer cells [ J ]. PNAS,2003,100 (7) :3983 - 3988.
  • 6Livasy CA, Karaca G, Nanda R, et al. Phenotypic evaluationof the basal- like subtype of invasive breast carcinoma[J]. Mod Pathol, 2006,19 (2) : 264 - 271.
  • 7Nielsen TO, Hsu FD, Jensen K, et al. Immunohistochemical and clinical characterization of the Basal - Like subtype of lnvasive breast careinoma [ J ]. Clinical Caneer Researeh, 2004,10(16) :5367 - 537.
  • 8Ponti D, Costa A, Zaffaroni N, et al. Isolation and in vitro- propagation of tumorigenic breast cancer cells with stem pro- genitor cell properties [ J ]. Cancer Res ,2005,65 ( 13 ) : 5506 -5511.
  • 9vant Veer LJ, Dai H, van de Vijver MJ, et al. Gene expres- sion profiling predicts clinical outcome of breast cancer[ J]. Nature ,2002,415 (6871) :530 - 536.
  • 10Page DL. Special types of invasive breast cancer,with clinical implications[J]. Am J Surg Pathol,2003,27(6) :832 -835.

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部